ADMA
Price
$16.31
Change
-$0.18 (-1.09%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
3.86B
64 days until earnings call
RLAY
Price
$4.34
Change
-$0.44 (-9.21%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
727.28M
36 days until earnings call
Ad is loading...

ADMA vs RLAY

Header iconADMA vs RLAY Comparison
Open Charts ADMA vs RLAYBanner chart's image
ADMA Biologics
Price$16.31
Change-$0.18 (-1.09%)
Volume$72.77K
Capitalization3.86B
Relay Therapeutics
Price$4.34
Change-$0.44 (-9.21%)
Volume$32.86K
Capitalization727.28M
ADMA vs RLAY Comparison Chart
Loading...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADMA vs. RLAY commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADMA is a Hold and RLAY is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (ADMA: $16.32 vs. RLAY: $4.34)
Brand notoriety: ADMA and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADMA: 103% vs. RLAY: 80%
Market capitalization -- ADMA: $3.86B vs. RLAY: $727.28M
ADMA [@Biotechnology] is valued at $3.86B. RLAY’s [@Biotechnology] market capitalization is $727.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADMA’s FA Score shows that 2 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • ADMA’s FA Score: 2 green, 3 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, ADMA is a better buy in the long-term than RLAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADMA’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 2 bullish TA indicator(s).

  • ADMA’s TA Score: 4 bullish, 5 bearish.
  • RLAY’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ADMA is a better buy in the short-term than RLAY.

Price Growth

ADMA (@Biotechnology) experienced а -10.77% price change this week, while RLAY (@Biotechnology) price change was -5.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

ADMA is expected to report earnings on May 07, 2025.

RLAY is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($3.86B) has a higher market cap than RLAY($727M). RLAY YTD gains are higher at: 5.461 vs. ADMA (-4.840). ADMA has higher annual earnings (EBITDA): 98.8M vs. RLAY (-389.45M). RLAY has more cash in the bank: 840M vs. ADMA (86.7M). RLAY has less debt than ADMA: RLAY (49.8M) vs ADMA (111M). ADMA has higher revenues than RLAY: ADMA (383M) vs RLAY (10M).
ADMARLAYADMA / RLAY
Capitalization3.86B727M531%
EBITDA98.8M-389.45M-25%
Gain YTD-4.8405.461-89%
P/E Ratio60.44N/A-
Revenue383M10M3,830%
Total Cash86.7M840M10%
Total Debt111M49.8M223%
FUNDAMENTALS RATINGS
ADMA: Fundamental Ratings
ADMA
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
13
SMR RATING
1..100
27
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
94
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADMARLAY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 7 days ago
87%
Momentum
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
80%
MACD
ODDS (%)
Bullish Trend 7 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
75%
Bullish Trend 7 days ago
74%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 28 days ago
77%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 7 days ago
77%
Bearish Trend 7 days ago
83%
View a ticker or compare two or three
Ad is loading...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSPFX6.260.08
+1.29%
Transamerica Small Cap Growth R4
RTDYX15.290.04
+0.26%
Russell Inv Multifactor US Equity Y
EVSTX20.330.04
+0.20%
Allspring Disciplined US Core C
AFDAX52.340.03
+0.06%
American Century Large Cap Equity A
AGTHX74.67-0.05
-0.07%
American Funds Growth Fund of Amer A

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with ATRA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then ATRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-1.03%
ATRA - ADMA
44%
Loosely correlated
-23.97%
RCUS - ADMA
41%
Loosely correlated
-0.79%
TARS - ADMA
38%
Loosely correlated
-5.72%
ACLX - ADMA
37%
Loosely correlated
-4.02%
LOGC - ADMA
36%
Loosely correlated
-2.56%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-9.10%
XNCR - RLAY
53%
Loosely correlated
-5.68%
CCCC - RLAY
44%
Loosely correlated
+6.86%
VCYT - RLAY
44%
Loosely correlated
-4.02%
RXRX - RLAY
43%
Loosely correlated
-6.23%
TVTX - RLAY
43%
Loosely correlated
-8.18%
More